Natco Pharma Limited
Indian Pharmaceutical Exporter ยท Immunosuppressants Specialist ยท $36.0M Total Trade ยท DGFT Verified
Natco Pharma Limited is an Indian pharmaceutical exporter with a total trade value of $36.0M across 17 products in 6 therapeutic categories. Based on 865 verified export shipments from Indian Customs (DGFT) records, Natco Pharma Limited is the #1 Indian exporter in 4 products including Everolimus, Oseltamivir, Lapatinib. Top exports include Everolimus ($11.2M), Oseltamivir ($8.8M), Apixaban ($3.6M).
Natco Pharma Limited โ Export Portfolio & Destination Treemap

Who is Natco Pharma Limited? โ Company Overview & Market Position
Natco Pharma Limited, established in 1981, is a vertically integrated pharmaceutical company headquartered in Hyderabad, India. The company specializes in the research, development, manufacturing, and marketing of finished dosage formulations (FDFs) and active pharmaceutical ingredients (APIs). Its product portfolio spans various therapeutic areas, including oncology, cardiology, diabetology, and gastroenterology. Natco Pharma is recognized for its focus on niche therapeutic segments and complex products, positioning itself as a leader in branded oncology medicines in India and among the top producers of hepatitis C drugs.
As of March 2025, Natco Pharma reported a revenue of $529.4 million, reflecting a 10.8% increase from the previous fiscal year. The company employs approximately 4,199 individuals across its operations. Natco Pharma's stock is listed on the National Stock Exchange of India under the ticker symbol NATCOPHARM.